Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 23;50(4):679-683.
doi: 10.3906/sag-2005-395.

The effects of blood group types on the risk of COVID-19 infection and its clinical outcome

Hakan Göker  1 , Elifcan Aladağ Karakulak  1 , Haluk Demiroğlu  1 , Çağlayan Merve Ayaz Ceylan  2 , Yahya Büyükaşik  1 , Ahmet Çağkan Inkaya  2 , Salih Aksu  1 , Nilgün Sayinalp  1 , Ibrahim Celalettin Haznedaroğlu  1 , Ömrüm Uzun  2 , Murat Akova  2 , Osman Ilhami Özcebe  1 , Serhat Ünal  1
Affiliations

The effects of blood group types on the risk of COVID-19 infection and its clinical outcome

Hakan Göker et al. Turk J Med Sci. .

Abstract

Background/aim: COVID-19 (Coronavirus disease of 2019) is an infectious disease outbreak later on declared as a pandemic, caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2). It spreads very rapidly and can result in severe acute respiratory failure. The clinical studies have shown that advanced age and chronic diseases increase the risk of infection. However, influence of the blood groups on COVID-19 infection and its outcome remains to be confirmed. The aim of this study is to investigate whether there exists a relationship between the blood groups of the patients and risk of SARS-CoV-2 infection and the clinical outcomes in COVID-19 patients

Material and method: 186 patients with PCR confirmed diagnosis of COVID-19 were included in this study. Age, sex, blood groups, comorbidities, need for intubation and intensive care unit follow up and mortalities of the patients were analyzed retrospectively. 1881 healthy individuals, who presented to the Hacettepe University Blood Bank served as the controls.

Results: The most frequently detected blood group was blood group A (57%) amongst the COVID-19 patients. This was followed by blood group O (24.8%). The blood group types did not affect the clinical outcomes. The blood group A was statistically significantly more frequent among those infected with COVID-19 compared to controls (57% vs. 38%, P < 0.001; OR: 2.1). On the other hand, the frequency of blood group O was significantly lower in the COVID-19 patients, compared to the control group (24.8% vs. 37.2%, P: 0.001; OR: 1.8).

Conclusions: The results of the present study suggest that while the blood group A might have a role in increased susceptibility to the COVID-19 infection, the blood group O might be somewhat protective. However, once infected, blood group type does not seem to influence clinical outcome.

Keywords: Blood groups; COVID-19; SARS-COV-2; susceptibility; clinical outcome.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST:

none declared

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zhou P Yang XL Wang XG Hu B Zhang L A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270. - PMC - PubMed
    1. Zhou F Yu T Du R Fan G Liu Y Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054. - PMC - PubMed
    1. Lindesmith L Moe C Marionneau S Ruvoen N Jiang X Human susceptibility and resistance to Norwalk virus infection. Nature Medicine. 2003;9:548. - PubMed
    1. Jing W Zhao S Liu J Liu M. ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis. BMJ Open. 2020;10 - PMC - PubMed
    1. Cheng Y Cheng G Chui CH Lau FY Chan PK ABO blood group and susceptibility to severe acute respiratory syndrome. The Journal of the American Medical Association. 2005;293:1450. - PubMed

MeSH terms

Substances